Medicare Enrolled

Dr. Steven Canfield, M.D.

Urology Physician · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Mixed engagement
6414 FANNIN ST, Houston, TX 77030
7137042494
In practice since 2006 (19 years)
NPI: 1598797276 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Canfield from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Canfield? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Canfield

Dr. Steven Canfield is an urology physician in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Canfield performed 335 Medicare services across 305 unique beneficiaries.

Between the years covered by Open Payments, Dr. Canfield received a total of $225,330 from 51 pharmaceutical and/or device companies across 386 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Canfield is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 335 Medicare services $225,330 industry payments

Medicare Practice Summary

Medicare Utilization ↗
335
Medicare services
Bottom 16% in TX for urology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
305
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~18 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min) 113 $63 $223
Office visit, established patient (30-39 min) 52 $92 $317
New patient office visit (30-44 min) 30 $79 $240
Bladder ultrasound after voiding 28 $8 $93
Automated urinalysis 28 $2 $15
Diagnostic exam of bladder and urethra using an endoscope 27 $180 $674
Electronic assessment of bladder emptying 25 $8 $314
New patient office visit (45-59 min) 16 $112 $379
Initial hospital admission, high complexity 16 $142 $519
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$225,330
Total received (2018-2024)
Avg $32,190/year across 7 years
Top 2% in TX for urology physician
51
Companies
386
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Other
Charitable contributions, space rental, and other categories
$106,257 (47.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$105,879 (47.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,126 (3.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,067 (2.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$60,893
2023
$56,358
2022
$14,296
2021
$7,976
2020
$13,791
2019
$37,144
2018
$34,872

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AngioDynamics, Inc.
$106,290
PFIZER INC.
$83,177
Astellas Pharma US Inc
$14,299
Progenics Pharmaceuticals, Inc.
$12,432
Pfizer Inc.
$3,500
Boston Scientific Corporation
$888
BOSTON SCIENTIFIC CORPORATION
$440
Ethicon US, LLC
$431
Baxter Healthcare
$285
Dendreon Pharmaceuticals LLC
$260
Axonics, Inc.
$250
Coloplast Corp
$226
Cook Medical LLC
$218
Janssen Biotech, Inc.
$208
Allergan Inc.
$202
Medtronic, Inc.
$168
Myovant Sciences Inc.
$145
Olympus America Inc.
$124
CONMED Corporation
$118
GENZYME CORPORATION
$117
Agiliti Surgical, Inc.
$113
EDAP TECHNOMED INC
$112
Bayer HealthCare Pharmaceuticals Inc.
$106
C. R. Bard, Inc. & Subsidiaries
$95
AbbVie Inc.
$86
COLOPLAST CORP
$71
Ferring Pharmaceuticals Inc.
$67
AbbVie, Inc.
$67
UroGen Pharma, Inc.
$62
Janssen Products, LP
$60
Photocure Inc
$59
Axonics Modulation Technologies, Inc.
$58
Bayer Healthcare Pharmaceuticals Inc.
$58
Travere Therapeutics, Inc.
$56
ABBVIE INC.
$56
Retrophin, Inc.
$53
Shire North American Group Inc
$40
Novartis Pharmaceuticals Corporation
$39
MEDIVATION FIELD SOLUTIONS LLC
$33
Ambu Inc.
$31
C. R. BARD, INC. & SUBSIDIARIES
$29
Covidien LP
$28
TETRAPHASE PHARMACEUTICALS, INC.
$23
Merck Sharp & Dohme Corporation
$23
PROCEPT BioRobotics Corporation
$23
AstraZeneca Pharmaceuticals LP
$22
Medtronic USA, Inc.
$22
Allergan, Inc.
$19
Sumitomo Pharma America, Inc.
$16
NxThera, Inc.
$12
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 90.4% of total payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · ADVANTAGE FIT · AIRSEAL · AMS · AquaBeam Robotic System · Axonics · Axonics r-SNM System · BIOSENTRY TRACT SEALANT SYSTEM · BOTOX · BOTOX THERAPEUTIC · Bulkamid · CLENPIQ · Cook Medical Urology · Cysview · ECHELON ENDOPATH Stapler · EVARREST · Echelon Flex · Endo GIA · Enseal X1 · Erleada · FLOSEAL · GATTEX · GENERAL BPH · GENERAL - BPH · GENERAL - FEMALE SUI · GENERAL BPH · Harmonic · INLAY OPTIMA · INTERSTIM · JELMYTO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Mega Soft · Myrbetriq · NANOKNIFE · NCIRCLE · NanoKnife · Nubeqa · ORGOVYX · Olympus Foreign Body Retrieval Devices · PLUVICTO · PROVENGE · PYLARIFY · Quanta CyberBlade · REZUM · Rezum · Rezum Generator · SKYLITE · SOLERO · SPEEDICATH · SUTENT · SWISS LITHOCLAST TRILOGY · SpaceOAR VUE System - 10mL · Syneture · THROMBIN · TISSEEL · TITAN · Thiola · Titan · UGN Laser Capital · XTANDI · Xerava · Xofigo · Xtandi · ZYTIGA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 2% for urology physician in TX.

Equivalent to $67,263 per 100 Medicare services performed
Looking for an urology physician in Houston?
Compare urology physicians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
198
Per 100K population
4.2
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Canfield is a clinical cardiology specialist, with moderate Medicare volume, with mixed engagement industry engagement in the top 2% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Canfield experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Canfield performed 113 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Canfield receive payments from pharmaceutical companies?
Yes. Dr. Canfield received a total of $225,330 from 51 companies across 386 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Canfield's costs compare to other urology physicians in Houston?
Dr. Canfield's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Canfield) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →